BridgeMD
Prevention study for Alcohol Consumption
Official title Enhancing HIV Prevention and Reducing Alcohol Use Among People Receiving STI Care in Lilongwe, Malawi
ClinicalTrials.gov ID: NCT06668363
What this study is testing
- What it's testing
- Purpose: To evaluate short-term efficacy and implementation of Treat4All, an alcohol reduction evidence-based intervention, for decreasing heavy drinking and optimizing HIV outcomes (viral suppression among People with HIV (PWH); Pre-exposure prophylaxis (PrEP) use among those at high risk of HIV) Participants: Approximately 160 participants aged 18 years or older will be enrolled into this study. Eligible participants will be recruited from two groups of individuals: Persons at risk of HIV: Individuals receiving (STI) care who report recent heavy drinking (n=80) and no recent use of PrEP.
- Time commitment: about 3 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Men and women age 18 years or older.
- Receiving care at Bwaila STI clinic.
- Report recent heavy drinking (greater than or equal to 4 drinks a day in the past 30 days for men and greater than or equal to 3 drinks a day in the...
- Willing to receive an HIV test at study enrollment, if not previously diagnosed Report not taking ART, recent suboptimal adherence to ART, or recent...
- Plan to reside in the Lilongwe area for at least 6 months.
You likely can't join if
- Unable to participate in study activities due to psychological disturbance, cognitive impairment, or threatening behavior
- Pregnant or breastfeeding
- At risk of experiencing alcohol-related withdrawal symptoms
- Acute physical or mental illness, including suicidal thoughts or behaviors
- Participating in in other HIV or alcohol programs
- Active drug dependence that would interfere with adherence to study requirements.
See the full eligibility criteria
- Men and women age 18 years or older.
- Receiving care at Bwaila STI clinic.
- Report recent heavy drinking (greater than or equal to 4 drinks a day in the past 30 days for men and greater than or equal to 3 drinks a day in the past 30 days for women
- Willing to receive an HIV test at study enrollment, if not previously diagnosed Report not taking ART, recent suboptimal adherence to ART, or recent history of unsuppressed HIV viral load [for PWH] or no recent oral...
- Plan to reside in the Lilongwe area for at least 6 months.
- Not participating in other HIV or alcohol programs
- Ability and willingness of participant to provide informed consent.
- Willingness to provide contact/locator information to be contacted for follow up study activities.
- Unable to participate in study activities due to psychological disturbance, cognitive impairment, or threatening behavior
- Pregnant or breastfeeding
- At risk of experiencing alcohol-related withdrawal symptoms
- Acute physical or mental illness, including suicidal thoughts or behaviors
- Participating in in other HIV or alcohol programs
- Active drug dependence that would interfere with adherence to study requirements.
- History of using injectible PrEP
- Any other condition that in the opinion of the study investigator would compromise the safety of the study participant or study staff or would prevent proper conduct of the study.
The study team makes the final eligibility decision.
Where it's taking place
- Lilongwe, Malawi
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 3 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lilongwe, Malawi. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.